Vulnerabilities

Security fix · CVE-2020-3955

ESXi 6.5 without patch ESXi650-201912104-SG and ESXi 6.7 without patch ESXi670-202004103-SG do not properly neutralize script-related HTML when viewing virtual machines attributes.

Published Apr 29, 2020 · catalog updated Jun 17, 2026 · ESXi 6.5 without patch

Last checked Nov 4, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2020-3955. EPSS is 1.34%. Act only if a listed version of ESXi 6.5 without patch is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (ESXi 6.5 without patch).
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Critical9.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
1.34%
Remediation
Advisory link
Affected products
cpe vmware/esxi

ESXi 6.5 without patch ESXi650-201912104-SG and ESXi 6.7 without patch ESXi670-202004103-SG do not properly neutralize script-related HTML when viewing virtual machines attributes. VMware has evaluated the severity of this issue to be in the Important severity range with a maximum CVSSv3 base score of 8.3.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe vmware/esxi6.5

How to fix CVE-2020-3955

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2020-3955. EPSS is 1.34%. Act only if a listed version of ESXi 6.5 without patch is installed.

Which versions are affected?

Compare what you have installed with 6.5. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 1.34%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 29, 2020 · Monitored products — critical

    Detected

    ESXi 6.5 without patch ESXi650-201912104-SG and ESXi 6.7 without patch ESXi670-202004103-SG do not properly neutralize script-related HTML when viewing virtual machines attributes. VMware has evaluated the severity of this issue to be in the Important severity range with a maximum CVSSv3 base score of 8.3.

  2. Jun 17, 2026 · Monitored products — critical

    Updated

    ESXi 6.5 without patch ESXi650-201912104-SG and ESXi 6.7 without patch ESXi670-202004103-SG do not properly neutralize script-related HTML when viewing virtual machines attributes. VMware has evaluated the severity of this issue to be in the Important severity range with a maximum CVSSv3 base score of 8.3.

Sources

  • CVE.orgVulnerability recordCVE-2020-3955

    Official CVE identifier

    cve.org
  • Monitored products — criticalVendor advisoryCVE-2020-3955

    ESXi 6.5 without patch ESXi650-201912104-SG and ESXi 6.7 without patch ESXi670-202004103-SG do not properly neutralize script-related HTML when viewing virtual machines attributes. VMware has evaluated the severity of this issue to be in the Important severity range with a maximum CVSSv3 base score of 8.3.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Nov 4, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • Monitored products — criticalNov 4, 2026
  • CVE.orgNov 2, 2026